Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 Diabetes
Clinical trial NCT05591235 · UNKNOWN
Trial details
- NCT number
- NCT05591235
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2022-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.